Table 2.
aAMCI |
AD |
Comparison aMCI-AD (*) |
||||
---|---|---|---|---|---|---|
CC portion | FA | MD | FA | MD | FA | MD |
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | p value | p value | |
CC1 | 0.47 (0.06) | 0.86 (0.11) | 0.45 (0.06) | 0.94 (0.10) | n.s. | 0.013 |
CC2 | 0.59 (0.06) | 0.90 (0.09) | 0.54 (0.07) | 0.98 (0.11) | 0.009 | 0.012 |
CC3 | 0.52 (0.06) | 0.97 (0.07) | 0.49 (0.05) | 1.04 (0.09) | 0.021 | 0.018 |
CC4 | 0.50 (0.07) | 1.04 (0.11) | 0.48 (0.07) | 1.12 (0.13) | n.s. | 0.034 |
CC5 | 0.58 (0.08) | 0.93 (0.09) | 0.54 (0.08) | 1.03 (0.15) | n.s. | 0.009 |
CC6 | 0.59 (0.09) | 1.01 (0.20) | 0.57 (0.09) | 1.13 (0.24) | n.s. | 0.039 |
CC7 | 0.54 (0.10) | 0.97 (0.15) | 0.53 (0.10) | 1.03 (0.13) | n.s. | n.s. |
Comparison between DTI-metrics (mean FA/MD) computed in the seven CC portions of the two groups (aMCI and AD patients).AD, Alzheimer’s disease; aMCI, amnestic mild cognitive impairment; CC, corpus callosum; FA, fractional anisotropy; MD, mean diffusivity. (*) p-values refer to t-test, significance level p < 0.05